Sphingosine-1-phosphate: Driver of NFκB and STAT3 Persistent Activation in Chronic Intestinal Inflammation and Colitis-associated Cancer

Overview

Journal JAKSTAT

Date 2013 Sep 27

PMID 24069553

Citations 17

Authors

Arianne L Theiss

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease is associated with an increased risk of colorectal cancer. Colitis-associated cancer is a classical inflammation-driven cancer in which constitutive NFκB and STAT3 activation drive tumorigenesis. Recent findings published by Liang et al. in Cancer Cell demonstrate that sphingosine kinase 1 (SphK1)-mediated upregulation of sphingosine-1-phosphate (S1P) drives a persistent NFκB/IL-6/STAT3/sphingosine-1-phosphate receptor 1 (S1PR1) amplification loop that is critical to the development of chronic colitis and colitis-associated cancer. FTY720, an antagonist of S1PR1, abolished persistent NFκB/IL-6/STAT3 signaling and reduced the development and progression of colitis-associated cancer. Targeting SphK1/S1P/S1PR1 may provide a therapeutic option to prevent the progression of colitis to cancer.

Citing Articles

The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?.

Morris G, Bortolasci C, Puri B, Marx W, ONeil A, Athan E Cytokine. 2021; 144:155593.

PMID: 34074585 PMC: 8149193. DOI: 10.1016/j.cyto.2021.155593.

Lipid Phosphate Phosphatases and Cancer.

Tang X, Brindley D Biomolecules. 2020; 10(9).

PMID: 32887262 PMC: 7564803. DOI: 10.3390/biom10091263.

POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling.

Shen Z, Feng X, Fang Y, Li Y, Li Z, Zhan Y Cell Death Dis. 2019; 10(11):863.

PMID: 31723122 PMC: 6853991. DOI: 10.1038/s41419-019-2046-7.

S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.

Tu Y, Xie P, Du X, Fan L, Bao Z, Sun G J Cell Mol Med. 2019; 23(10):6907-6918.

PMID: 31430050 PMC: 6787445. DOI: 10.1111/jcmm.14574.

CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.

Qin Y, Wang J, Zhu G, Li G, Tan H, Chen C J Cell Mol Med. 2019; 23(4):2689-2701.

PMID: 30768878 PMC: 6433669. DOI: 10.1111/jcmm.14168.

References

Snider A, Kawamori T, Bradshaw S, Orr K, Gilkeson G, Hannun Y . A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 2008; 23(1):143-52. PMC: 2626622. DOI: 10.1096/fj.08-118109. View

Spiegel S, Milstien S . Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003; 4(5):397-407. DOI: 10.1038/nrm1103. View

Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Bielawski J . Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 2008; 23(2):405-14. PMC: 2630788. DOI: 10.1096/fj.08-117572. View

Grivennikov S, Karin E, Terzic J, Mucida D, Yu G, Vallabhapurapu S . IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009; 15(2):103-13. PMC: 2667107. DOI: 10.1016/j.ccr.2009.01.001. View

Bollrath J, Greten F . IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep. 2009; 10(12):1314-9. PMC: 2799209. DOI: 10.1038/embor.2009.243. View

Pyne N, Pyne S . Sphingosine 1-phosphate and cancer. Nat Rev Cancer. 2010; 10(7):489-503. DOI: 10.1038/nrc2875. View

Brentnall T, Crispin D, Rabinovitch P, Haggitt R, RUBIN C, Stevens A . Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994; 107(2):369-78. DOI: 10.1016/0016-5085(94)90161-9. View

Deguchi Y, Andoh A, Yagi Y, Bamba S, Inatomi O, Tsujikawa T . The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncol Rep. 2006; 16(4):699-703. View

Tonelli F, Lim K, Loveridge C, Long J, Pitson S, Tigyi G . FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal. 2010; 22(10):1536-42. PMC: 2947314. DOI: 10.1016/j.cellsig.2010.05.022. View

10.

Atreya R, Neurath M . Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets. 2008; 9(5):369-74. DOI: 10.2174/138945008784221116. View

11.

Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M . STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009; 206(7):1465-72. PMC: 2715097. DOI: 10.1084/jem.20082683. View

12.

Daniel C, Sartory N, Zahn N, Schmidt R, Geisslinger G, Radeke H . FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol Immunol. 2007; 44(13):3305-16. DOI: 10.1016/j.molimm.2007.02.026. View

13.

Bollrath J, Phesse T, von Burstin V, Putoczki T, Bennecke M, Bateman T . gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009; 15(2):91-102. DOI: 10.1016/j.ccr.2009.01.002. View

14.

Lakatos P, Lakatos L . Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol. 2008; 14(25):3937-47. PMC: 2725331. DOI: 10.3748/wjg.14.3937. View

15.

Daniel C, Sartory N, Zahn N, Geisslinger G, Radeke H, Stein J . FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J Immunol. 2007; 178(4):2458-68. DOI: 10.4049/jimmunol.178.4.2458. View

16.

Lee H, Herrmann A, Deng J, Kujawski M, Niu G, Li Z . Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell. 2009; 15(4):283-93. PMC: 2777654. DOI: 10.1016/j.ccr.2009.02.015. View

17.

Corvinus F, Orth C, Moriggl R, Tsareva S, Wagner S, Pfitzner E . Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia. 2005; 7(6):545-55. PMC: 1501283. DOI: 10.1593/neo.04571. View

18.

Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A . STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med. 2010; 16(12):1421-8. PMC: 3088498. DOI: 10.1038/nm.2250. View

19.

Alvarez S, Harikumar K, Hait N, Allegood J, Strub G, Kim E . Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010; 465(7301):1084-8. PMC: 2946785. DOI: 10.1038/nature09128. View

20.

Canavan C, Abrams K, Mayberry J . Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006; 23(8):1097-104. DOI: 10.1111/j.1365-2036.2006.02854.x. View